Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 2
1994 2
1995 4
1996 3
1997 2
1998 2
1999 2
2000 1
2001 1
2002 3
2003 3
2004 1
2006 4
2007 2
2008 3
2009 3
2010 9
2011 17
2012 19
2013 14
2014 20
2015 34
2016 26
2017 37
2018 41
2019 23
2020 19
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 22344503

261 results
Results by year
Filters applied: . Clear all
Page 1
Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.
Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, Li J, King BF, Martin D, Wetzel LH, Lockhart ME, Harris PC, Moxey-Mims M, Flessner M, Bennett WM, Grantham JJ. Chapman AB, et al. Clin J Am Soc Nephrol. 2012 Mar;7(3):479-86. doi: 10.2215/CJN.09500911. Epub 2012 Feb 16. Clin J Am Soc Nephrol. 2012. PMID: 22344503 Free PMC article.
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
Yu ASL, Shen C, Landsittel DP, Harris PC, Torres VE, Mrug M, Bae KT, Grantham JJ, Rahbari-Oskoui FF, Flessner MF, Bennett WM, Chapman AB; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Yu ASL, et al. Kidney Int. 2018 Mar;93(3):691-699. doi: 10.1016/j.kint.2017.09.027. Epub 2017 Dec 28. Kidney Int. 2018. PMID: 29290310 Free PMC article.
A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.
Bhutani H, Smith V, Rahbari-Oskoui F, Mittal A, Grantham JJ, Torres VE, Mrug M, Bae KT, Wu Z, Ge Y, Landslittel D, Gibbs P, O'Neill WC, Chapman AB; CRISP Investigators. Bhutani H, et al. Kidney Int. 2015 Jul;88(1):146-51. doi: 10.1038/ki.2015.71. Epub 2015 Apr 1. Kidney Int. 2015. PMID: 25830764 Free PMC article.
Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE, Meijer E, de Jong PE, ter Horst GJ, Renken RJ, van der Jagt EJ, Kappert P, Ouyang J, Engels GE, van Oeveren W, Struck J, Czerwiec FS, Oberdhan D, Krasa HB, Gansevoort RT. Boertien WE, et al. Am J Kidney Dis. 2015 Jun;65(6):833-41. doi: 10.1053/j.ajkd.2014.11.010. Epub 2015 Jan 15. Am J Kidney Dis. 2015. PMID: 25600953
Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.
Sans L, Pascual J, Radosevic A, Quintian C, Ble M, Molina L, Mojal S, Ballarin JA, Torra R, Fernández-Llama P. Sans L, et al. Medicine (Baltimore). 2016 Dec;95(49):e5595. doi: 10.1097/MD.0000000000005595. Medicine (Baltimore). 2016. PMID: 27930582 Free PMC article.
Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
Kline TL, Korfiatis P, Edwards ME, Bae KT, Yu A, Chapman AB, Mrug M, Grantham JJ, Landsittel D, Bennett WM, King BF, Harris PC, Torres VE, Erickson BJ; CRISP Investigators. Kline TL, et al. Kidney Int. 2017 Nov;92(5):1206-1216. doi: 10.1016/j.kint.2017.03.026. Epub 2017 May 20. Kidney Int. 2017. PMID: 28532709 Free PMC article.
Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease.
Sans L, Radosevic A, Quintian C, Montañés R, Gràcia S, Vilaplana C, Mojal S, Ballarin JA, Fernández-Llama P, Torra R, Pascual J. Sans L, et al. PLoS One. 2017 Mar 27;12(3):e0174583. doi: 10.1371/journal.pone.0174583. eCollection 2017. PLoS One. 2017. PMID: 28346513 Free PMC article.
Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
Miskulin DC, Abebe KZ, Chapman AB, Perrone RD, Steinman TI, Torres VE, Bae KT, Braun W, Winklhofer FT, Hogan MC, Rahbari-Oskoui F, Moore CG, Flessner MF, Schrier RW; HALT-PKD Study. Miskulin DC, et al. Am J Kidney Dis. 2014 Feb;63(2):214-26. doi: 10.1053/j.ajkd.2013.08.017. Epub 2013 Nov 1. Am J Kidney Dis. 2014. PMID: 24183837 Free PMC article. Clinical Trial.
The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M, Inci A. Coban M, et al. Int Urol Nephrol. 2018 Jul;50(7):1293-1300. doi: 10.1007/s11255-018-1866-1. Epub 2018 Apr 13. Int Urol Nephrol. 2018. PMID: 29654395
Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
Messchendorp AL, Meijer E, Visser FW, Engels GE, Kappert P, Losekoot M, Peters DJM, Gansevoort RT; on behalf of the DIPAK-1 study investigators. Messchendorp AL, et al. Am J Nephrol. 2019;50(5):375-385. doi: 10.1159/000502999. Epub 2019 Oct 10. Am J Nephrol. 2019. PMID: 31600749 Free PMC article.
261 results
Jump to page
Feedback